Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Langenberg

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Hemasphere|July 16, 2024
Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experienceJudith M Boer, Uri Ilan, Aurélie Boeree, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Myeloproliferative Neoplasm Driven by <i>ETV6-ABL1</i> in an Adolescent with Recent History of Burkitt LeukemiaSamuele Renzi, Fatimah Algawahmed, Scott Davidson, et al.
Cancers|January 11, 2025
Prognostic Value of Molecular Aberrations in Low- or Intermediate-Risk Neuroblastomas: A Systematic ReviewRixt S Bruinsma, Caroline W M Lekkerkerker, Marta Fiocco, et al.
JCO Precision Oncology|March 12, 2026
Effect of <i>MYCN</i> Amplification on Tumor Response and Recurrence in Patients With Stage IV NeuroblastomaYvette A H Matser, André B P van Kuilenburg, Atia Samim, et al.
BMC Cancer|April 5, 2023
The potential of PARP as a therapeutic target across pediatric solid malignanciesKaylee M Keller, Joost Koetsier, Linda Schild, et al.
Cell Reports|August 25, 2021
Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumorsCamilla Calandrini, Sander R van Hooff, Irene Paassen, et al.
JCO Precision Oncology|February 21, 2025
Urinary Catecholamines Predict Relapse During Complete Remission in High-Risk NeuroblastomaYvette A H Matser, Atia Samim, Marta Fiocco, et al.
JAMA Network Open|February 3, 2023
Assessment of Cancer Predisposition Syndromes in a National Cohort of Children With a NeoplasmJette J Bakhuizen, Saskia M J Hopman, Machteld I Bosscha, et al.
Frontiers in Oncology|September 4, 2023
Case series on clinical applications of liquid biopsy in pediatric solid tumors: towards improved diagnostics and disease monitoringNina U Gelineau, Astrid van Barneveld, Atia Samim, et al.
JCO Precision Oncology|June 26, 2023
Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORMAnna-Elisa Heipertz, Kristian W Pajtler, Elke Pfaff, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Hemasphere|July 16, 2024
Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experienceJudith M Boer, Uri Ilan, Aurélie Boeree, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Myeloproliferative Neoplasm Driven by <i>ETV6-ABL1</i> in an Adolescent with Recent History of Burkitt LeukemiaSamuele Renzi, Fatimah Algawahmed, Scott Davidson, et al.
Cancers|January 11, 2025
Prognostic Value of Molecular Aberrations in Low- or Intermediate-Risk Neuroblastomas: A Systematic ReviewRixt S Bruinsma, Caroline W M Lekkerkerker, Marta Fiocco, et al.
JCO Precision Oncology|March 12, 2026
Effect of <i>MYCN</i> Amplification on Tumor Response and Recurrence in Patients With Stage IV NeuroblastomaYvette A H Matser, André B P van Kuilenburg, Atia Samim, et al.
BMC Cancer|April 5, 2023
The potential of PARP as a therapeutic target across pediatric solid malignanciesKaylee M Keller, Joost Koetsier, Linda Schild, et al.
Cell Reports|August 25, 2021
Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumorsCamilla Calandrini, Sander R van Hooff, Irene Paassen, et al.
JCO Precision Oncology|February 21, 2025
Urinary Catecholamines Predict Relapse During Complete Remission in High-Risk NeuroblastomaYvette A H Matser, Atia Samim, Marta Fiocco, et al.
JAMA Network Open|February 3, 2023
Assessment of Cancer Predisposition Syndromes in a National Cohort of Children With a NeoplasmJette J Bakhuizen, Saskia M J Hopman, Machteld I Bosscha, et al.
Frontiers in Oncology|September 4, 2023
Case series on clinical applications of liquid biopsy in pediatric solid tumors: towards improved diagnostics and disease monitoringNina U Gelineau, Astrid van Barneveld, Atia Samim, et al.
JCO Precision Oncology|June 26, 2023
Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORMAnna-Elisa Heipertz, Kristian W Pajtler, Elke Pfaff, et al.
Pageof 3